Wolff-Parkinson-White Syndrome for USMLE

TLDR;

This video provides a comprehensive overview of Wolff-Parkinson-White (WPW) syndrome, differentiating between WPW pattern and WPW syndrome. It covers the pathophysiology, focusing on the Bundle of Kent, its association with Ebstein anomaly and lithium exposure, key ECG findings like delta waves and short PR intervals, and acute and long-term management strategies, including when to use electrical cardioversion and which AV nodal blocking agents to avoid.

• WPW pattern is identified by ECG evidence of ventricular pre-excitation, while WPW syndrome includes both ECG changes and symptoms of arrhythmia.
• The Bundle of Kent, an accessory pathway, bypasses the AV node, leading to faster impulse transmission from the atria to the ventricles.
• Acute management involves assessing hemodynamic stability and avoiding AV nodal blocking agents like adenosine and beta-blockers.
• Long-term management includes risk stratification and catheter ablation for high-risk and symptomatic low-risk patients.

WPW Pattern vs. WPW Syndrome [0:00]

The lecture introduces Wolff-Parkinson-White (WPW), distinguishing between WPW pattern and WPW syndrome. WPW pattern is defined by ECG evidence of ventricular pre-excitation complexes without any reported symptoms or arrhythmia. In contrast, WPW syndrome includes both ECG changes indicative of ventricular pre-excitation, as well as evidence of arrhythmia and reported symptoms from the patient.

Pathophysiology: The Bundle of Kent & Accessory Pathways [0:44]

The main pathophysiology of WPW syndrome involves intermittent tachycardia due to an accessory pathway known as the bundle of Kent. This bundle bypasses the AV node, allowing impulses from the SA node to propagate directly into the ventricles. Bypassing the AV node allows impulses to pass from the atria to the ventricles more quickly than normal.

Association with Ebstein Anomaly & Lithium Exposure [1:19]

WPW syndrome can be associated with Ebstein anomaly, which has a strong correlation with maternal lithium exposure. Lithium, a mood-stabilizing agent used in bipolar disorders, increases the risk of fetal anomalies, including those associated with WPW syndrome. Additionally, WPW syndrome is linked to arrhythmias like atrioventricular reciprocating tachycardia (AVRT), atrial fibrillation, and atrial flutter.

High-Yield ECG Findings: Delta Waves & Short PR Interval [2:05]

Key ECG findings in WPW syndrome include changes resulting from the bundle of Kent bypassing the AV node. This bypass leads to a shortened PR interval, reflecting the faster transmission of impulses from the atria to the ventricles. A delta wave, which is the slurring of the upstroke of the QRS complex, indicates impulse transmission through the accessory pathway. These changes result in widening of the QRS complexes, although the delta wave may not be present in all patients.

Acute Management: When to use Electrical Cardioversion [3:54]

Acute management of WPW syndrome involves assessing the patient's hemodynamic stability. If the patient is hemodynamically unstable, electrical cardioversion should be performed immediately. For hemodynamically stable patients with wide-complex tachycardia, rhythm control measures such as cardioversion or drugs like ibutilide can be used.

CRITICAL: AV Nodal Blocking Agents to avoid (Adenosine, Beta-blockers, CCBs) [4:31]

It is critical to avoid AV nodal blocking agents such as adenosine, beta-blockers, non-dihydropyridine calcium channel blockers (verapamil and diltiazem), and digoxin, as they can precipitate fatal ventricular tachycardia or ventricular fibrillation. Vagal maneuvers should also be avoided because they increase AV node activity, potentially leading to dangerous arrhythmias. For patients with regular narrow-complex tachycardia who are hemodynamically stable, vagal maneuvers or adenosine can be considered.

Long-term Management & Radiofrequency Catheter Ablation [5:25]

Long-term management of WPW syndrome involves risk stratification based on clinical history and electrophysiological parameters. High-risk patients are typically managed with catheter ablation (radiofrequency ablation) of the accessory pathway. For low-risk patients, management depends on whether they are symptomatic. Asymptomatic patients are simply observed, while symptomatic patients are primarily treated with catheter ablation of the bundle of Kent. Second-line management includes long-term antiarrhythmics such as dofetilide and sotalol for those with structural heart disease, or flecainide and propafenone for those without structural heart disease.